Peter A Kiener - Net Worth and Insider Trading
Peter A Kiener Net Worth
The estimated net worth of Peter A Kiener is at least $36,850 dollars as of 2024-12-01. Peter A Kiener is the Chief Science Officer of Sucampo Pharmaceuticals Inc and owns about 2,023 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $36,414. Peter A Kiener is also the Director of Cue Biopharma Inc and owns about 357 shares of Cue Biopharma Inc (CUE) stock worth over $436. Details can be seen in Peter A Kiener's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter A Kiener has not made any transactions after 2023-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter A Kiener
Peter A Kiener Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter A Kiener owns 3 companies in total, including Pieris Pharmaceuticals Inc (PIRS) , Cue Biopharma Inc (CUE) , and Sucampo Pharmaceuticals Inc (SCMP) .
Click here to see the complete history of Peter A Kiener’s form 4 insider trades.
Insider Ownership Summary of Peter A Kiener
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2023-06-21 | director |
| CUE | Cue Biopharma Inc | 2023-03-23 | director |
| SCMP | Sucampo Pharmaceuticals Inc | 2018-02-13 | Chief Science Officer |
Peter A Kiener Latest Holdings Summary
Peter A Kiener currently owns a total of 2 stocks. Among these stocks, Peter A Kiener owns 2,023 shares of Sucampo Pharmaceuticals Inc (SCMP) as of December 7, 2017, with a value of $36,414 and a weighting of 98.82%. Peter A Kiener also owns 357 shares of Cue Biopharma Inc (CUE) as of March 23, 2023, with a value of $436 and a weighting of 1.18%.
Latest Holdings of Peter A Kiener
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCMP | Sucampo Pharmaceuticals Inc | 2017-12-07 | 2,023 | 18.00 | 36,414 |
| CUE | Cue Biopharma Inc | 2023-03-23 | 357 | 1.22 | 436 |
Holding Weightings of Peter A Kiener
Peter A Kiener Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter A Kiener has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 50,000 shares on December 7, 2017, which brought Peter A Kiener around $825,000.
According to the SEC Form 4 filings, Peter A Kiener has made a total of 2 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cue Biopharma Inc is the sale of 9,325 shares on March 23, 2023, which brought Peter A Kiener around $30,586.
Insider Trading History of Peter A Kiener
- 1
Peter A Kiener Trading Performance
Peter A Kiener Ownership Network
Peter A Kiener Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Peter A Kiener is the director of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Peter A Kiener made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Peter A Kiener Mailing Address
Above is the net worth, insider trading, and ownership report for Peter A Kiener. You might contact Peter A Kiener via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
